NCT04382885View on ClinicalTrials.gov

Cariprazine Pediatric ASD PK Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Cariprazine

Oral Solution

Trial Locations (3)

30030

iResearch Atlanta, LLC /ID# 233614, Decatur

30331

Atlanta Center for Medical Research /ID# 233576, Atlanta

92868

Neuropsychiatric Research Center of Orange County /ID# 233663, Orange

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY